Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma: 8 vs 4 Induction Cycles; the Carthadex Trial
Publication date
2020-08
Authors
Wester, Ruth
Zweegman, Sonja
van der Holt, Bronno
Kersten, Marie José
Vellenga, Edo
van Marwijk-Kooy, Marinus
Asselbergs, Emelie
de Weerdt, Okke
Minnema, Monique
Lonergan, Sarah
Editors
Advisors
Supervisors
Document Type
Letter
Metadata
Show full item recordCollections
License
Abstract
Keywords
Journal Article
Citation
Wester, R, Zweegman, S, van der Holt, B, Kersten, M J, Vellenga, E, van Marwijk-Kooy, M, Asselbergs, E, de Weerdt, O, Minnema, M C, Lonergan, S, Palumbo, A, Broijl, A & Sonneveld, P 2020, 'Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma : 8 vs 4 Induction Cycles; the Carthadex Trial', HemaSphere, vol. 4, no. 4, e370. https://doi.org/10.1097/HS9.0000000000000370